The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition.
The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition.
复制标题
DOI:
10.1186/bcr2347
复制
发表时间:
2009
期刊:
影响因子:
--
通讯作者:
Allalunis-Turner J
中科院分区:
文献类型:
--
作者:
Han J;Ma I;Hendzel MJ;Allalunis-Turner J
Notch is a family of transmembrane protein receptors whose activation requires proteolytic cleavage by γ-secretase. Since aberrant Notch signaling can induce mammary carcinomas in transgenic mice and high expression levels of Notch receptors and ligands correlates with overall poor clinical outcomes, inhibiting γ-secretase with small molecules may be a promising approach for breast cancer treatment. Consistent with this hypothesis, two recent papers reported that γ-secretase inhibitor I (GSI I), Z-LLNle-CHO, is toxic to breast cancer cells both in vitro and in vivo. In this study, we compared the activity and cytotoxicity of Z-LLNle-CHO to that of two highly specific GSIs, DAPT and L-685,458 and three structurally unrelated proteasome inhibitors, MG132, lactacystin, and bortezomib in order to study the mechanism underlying the cytotoxicity of Z-LLNle-CHO in breast cancer cells. Three estrogen receptor (ER) positive cell lines, MCF-7, BT474, and T47D, and three ER negative cell lines, SKBR3, MDA-MB-231, and MDA-MB-468, were used in this study. Both SKBR3 and BT474 cells also overexpress HER2/neu. Cytotoxicity was measured by using an MTS cell viability/proliferation assay. Inhibition of γ-secretase activity was measured by both immunoblotting and immunofluorescent microscopy in order to detect active Notch1 intracellular domain. Proteasome inhibition was determined by using a cell-based proteasome activity assay kit, by immunoblotting to detect accumulation of polyubiquitylated protein, and by immunofluorescent microscopy to detect redistribution of cellular ubiquitin. We found that blocking γ-secretase activity by DAPT and L-685,458 had no effect on the survival and proliferation of a panel of six breast cancer cell lines while Z-LLNle-CHO could cause cell death even at concentrations that inhibited γ-secretase activity less efficiently. Furthermore, we observed that Z-LLNle-CHO could inhibit proteasome activity and the relative cellular sensitivity of these six breast cancer cell lines to Z-LLNle-CHO was the same as observed for three proteasome inhibitors. Finally, we found that the cell killing effect of Z-LLNle-CHO could be reversed by a chemical that restored the proteasome activity. We conclude that the cytotoxicity of Z-LLNle-CHO in breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition.
登录
查看更多内容
影响因子:
4.6
作者:
Denlinger, CE;Rundall, BK;Jones, DR
通讯作者:
Jones, DR
影响因子:
5.3
作者:
Rand, MD;Grimm, LM;Aster, JC
通讯作者:
Aster, JC
影响因子:
11.2
作者:
Ban J;Bennani-Baiti IM;Kauer M;Schaefer KL;Poremba C;Jug G;Schwentner R;Smrzka O;Muehlbacher K;Aryee DN;Kovar H
通讯作者:
Kovar H
影响因子:
11.2
作者:
Rizzo P;Miao H;D'Souza G;Osipo C;Song LL;Yun J;Zhao H;Mascarenhas J;Wyatt D;Antico G;Hao L;Yao K;Rajan P;Hicks C;Siziopikou K;Selvaggi S;Bashir A;Bhandari D;Marchese A;Lendahl U;Qin JZ;Tonetti DA;Albain K;Nickoloff BJ;Miele L
通讯作者:
Miele L
影响因子:
2.5
作者:
Callahan, R;Raafat, A
通讯作者:
Raafat, A